Charles Schwab’s T2 Biosystems, Inc TTOO Stock Holding History

Charles Schwab’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34	Closed	-$20K	–	3574
2022 Q3	$20K	Hold	34	–	–	﹤0.01%	3480
2022 Q2	$28K	Buy	+34	New	+$50.4K	﹤0.01%	3489
2022 Q1	–	Sell	-10	Closed	-$25K	–	3636
2021 Q4	$25K	Hold	10	–	–	﹤0.01%	3573
2021 Q3	$44K	Hold	10	–	–	﹤0.01%	3466
2021 Q2	$57K	Hold	10	–	–	﹤0.01%	3351
2021 Q1	$77K	Hold	10	–	–	﹤0.01%	3402
2020 Q4	$59K	Hold	10	–	–	﹤0.01%	3346
2020 Q3	$65K	Hold	10	–	–	﹤0.01%	3270
2020 Q2	$61K	Buy	+10	New	+$42.5K	﹤0.01%	3255
2019 Q2	–	Sell	-14	Closed	-$181K	–	3276
2019 Q1	$181K	Hold	14	–	–	﹤0.01%	3040
2018 Q4	$207K	Hold	14	–	–	﹤0.01%	3014
2018 Q3	$511K	Buy	14 +3	+27%	+$98.8K	﹤0.01%	2832
2018 Q2	$444K	Buy	+11	New	+$417K	﹤0.01%	2842
2017 Q2	–	Sell	-4	Closed	-$114K	–	3148
2017 Q1	$114K	Hold	4	–	–	﹤0.01%	3000
2016 Q4	$114K	Hold	4	–	–	﹤0.01%	3034
2016 Q3	$157K	Hold	4	–	–	﹤0.01%	2960
2016 Q2	$171K	Hold	4	–	–	﹤0.01%	2987
2016 Q1	$213K	Hold	4	–	–	﹤0.01%	2883
2015 Q4	$237K	Buy	+4	New	+$216K	﹤0.01%	2928

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Charles Schwab's TTOO Position: Q4 2022 in Review

Charles Schwab sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 34 shares — an estimated $20K sold.

Charles Schwab first reported a position in TTOO in Q4 2015 and held it in 19 quarters. The position peaked at $511K in Q3 2018. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

Charles Schwab reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
Charles Schwab sold 34 T2 Biosystems, Inc shares in Q4 2022, an estimated $20K.
Charles Schwab first reported a position in T2 Biosystems, Inc in Q4 2015 and held it in 19 quarters.
Charles Schwab's T2 Biosystems, Inc position peaked at $511K in Q3 2018.
20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.